Cisapride, which can reduce total and segmental CTT, is an effective drug in chronic functional constipation. 西沙必利能显著缩短慢性功能性便秘患者的全结肠及各节段结肠转运时间，可常规用于慢性功能性便秘患者。
Conclusion Plasma medium molecular substance content increases in functional constipation patients. 结论功能性便秘患者血浆内中分子物质含量增加。
